First US trial of bone-marrow stem cells for heart attack patients proves safe
Tuesday, September 14, 2010 - 10:35
in Health & Medicine
The first randomized, placebo-controlled U.S. clinical trial to assess the use of bone marrow-derived mononuclear cells (BMC) in patients after a ST-elevation myocardial infarction (STEMI; severe...